US Alzheimer's diagnoses tripled among 30- to 64-year-olds according to a Blue Cross and Blue Shield analysis

Get the Full StoryThis story was delivered to Business Insider Intelligence Digital Health Pro subscribers earlier this morning.

To get this story plus others to your inbox each day, hours before they're published on Business Insider, click here.

A new analysis of Blue Cross and Blue Shield health insurance claims from 2013 to 2017 showed that early onset dementia and Alzheimer's disease diagnoses tripled among commercially insured adults in the US ages 30 to 64, according to Forbes.

Business Insider Intelligence

We've seen some digital health players start making strides in better assessing cognitive impairment. For example, in November 2019, Dutch health tech giant Philips launched its IntelliSpace Cognition digital platform to help clinicians quickly assess, quantify, and track patients' cognitive impairment over time.See the rest of the story at Business InsiderSee Also:Apple ties up with Johnson & Johnson to study atrial fibrillation and stroke riskVirtual care firm Babylon fired back at a doctor critiquing its chatbot by publicly posting his data on TwitterThese 7 biotechs face a make-or-break 2020 as they chase a 9.6 billion market to treat a disease that has no cure

Share: